Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15034868rdf:typepubmed:Citationlld:pubmed
pubmed-article:15034868lifeskim:mentionsumls-concept:C0006141lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C0205282lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C0665341lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C0334094lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C0205183lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C0205214lld:lifeskim
pubmed-article:15034868lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:15034868pubmed:issue1lld:pubmed
pubmed-article:15034868pubmed:dateCreated2004-3-22lld:pubmed
pubmed-article:15034868pubmed:abstractTextAlterations in estrogen responsive pathways are thought to contribute to benign and malignant breast disease. It has been reported previously that more than a third of typical epithelial hyperplasia lesions harbor the missense mutation A908G in the estrogen receptor alpha (ESR1) gene. This substitution of an arginine for a lysine at codon 303 was reported to confer mitogenic hypersensitivity to estrogen. To explore this finding further, we analyzed ESR1 for this mutation in a series of breast tissues ranging from typical hyperplasia to invasive cancer. In contrast to previous studies, no evidence for this mutation was found in 36 invasive cancers, 11 in situ carcinomas, 14 epithelial hyperplasias with atypia, 11 epithelial hyperplasias without atypia, and 11 breast cancer cell lines. These results indicate that ESR1 mutant A908G does not occur with significant frequency in either benign or malignant proliferations of breast epithelia.lld:pubmed
pubmed-article:15034868pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034868pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034868pubmed:languageenglld:pubmed
pubmed-article:15034868pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034868pubmed:citationSubsetIMlld:pubmed
pubmed-article:15034868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034868pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034868pubmed:statusMEDLINElld:pubmed
pubmed-article:15034868pubmed:monthMaylld:pubmed
pubmed-article:15034868pubmed:issn1045-2257lld:pubmed
pubmed-article:15034868pubmed:authorpubmed-author:BentleyRex...lld:pubmed
pubmed-article:15034868pubmed:authorpubmed-author:MarksJeffrey...lld:pubmed
pubmed-article:15034868pubmed:authorpubmed-author:OlsonJohn...lld:pubmed
pubmed-article:15034868pubmed:authorpubmed-author:TebbitChristo...lld:pubmed
pubmed-article:15034868pubmed:copyrightInfoCopyright 2004 Wiley-Liss, Inc.lld:pubmed
pubmed-article:15034868pubmed:issnTypePrintlld:pubmed
pubmed-article:15034868pubmed:volume40lld:pubmed
pubmed-article:15034868pubmed:ownerNLMlld:pubmed
pubmed-article:15034868pubmed:authorsCompleteYlld:pubmed
pubmed-article:15034868pubmed:pagination51-4lld:pubmed
pubmed-article:15034868pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:meshHeadingpubmed-meshheading:15034868...lld:pubmed
pubmed-article:15034868pubmed:year2004lld:pubmed
pubmed-article:15034868pubmed:articleTitleEstrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast.lld:pubmed
pubmed-article:15034868pubmed:affiliationDepartment of Surgery, Duke University Medical Center, Durham, NC 27710, USA.lld:pubmed
pubmed-article:15034868pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15034868pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:2099entrezgene:pubmedpubmed-article:15034868lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15034868lld:entrezgene
lhgdn:association:52487lhgdn:found_inpubmed-article:15034868lld:lhgdn
lhgdn:association:52580lhgdn:found_inpubmed-article:15034868lld:lhgdn
lhgdn:association:52710lhgdn:found_inpubmed-article:15034868lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15034868lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15034868lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15034868lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15034868lld:pubmed